Skip to content
EBCC12 Logo

Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer

pruyskart2022-05-03T08:49:43+01:00
©Copyright 2019 - EBCC 12 | Privacy Policy | All Rights Reserved
Contact us

VAT: Belgium: BE 0408 292 992
Page load link
Go to Top